tumor necrosis

tumor necrosis

Death of tumor tissue, a common event in aggressive CAs in which the tumor rapidly outgrows its blood supply, resulting in tumor cell death. Cf Apoptosis.
References in periodicals archive ?
Global Markets Direct's, 'Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016', provides in depth analysis on Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) targeted pipeline therapeutics.
For this study, the focus was tumor necrosis factor alpha, a proinflammatory cytokine that helps regulate immune cells and is a major player in arthritis.
We've also shown that the tumor necrosis factor-triggered MAP4K4 is a direct target of miR-30d.
Changes in the effects of interleukin-1beta and tumor necrosis factor-alpha on platelet activation in early pregnancy.
The medications target chronic inflammation symptomatic of RA by interfering with a pro-inflammatory substance called tumor necrosis factor (TNF).
Tumor necrosis factor (TNF) ligand is a member of a superfamily of proteins, each with 157 amino acids, which induce the death of tumor cells and possess proinflammatory actions.
We determined the effects of theaflavin, a black tea-derived polyphenol, on tumor necrosis factor-alpha-mediated expression of the interleukin-8 gene in A549 cells.
Schering Corporation (Kenilworth, NJ) has patented a modified tumor necrosis factor-alpha converting enzyme catalytic domain, that unlike the native tumor necrosis factor-alpha converting enzyme catalytic domain, is stable at high protein concentrations.
Although lead and lipopolysaccharide (LPS), both important environmental pollutants, activate cells through different receptors and participate in distinct upstream signaling pathways, Pb increases the amount of LPS-induced tumor necrosis factor-[alpha] (TNF-[alpha]).
Certain cytokines (interleukin [IL]-1 and tumor necrosis factor [TNF]-[alpha], but not viral replication, correlate with cardiac inflammation and can overcome resistance to chronic myocarditis (7-9).
Advanced Biotherapy is working with a protein called Tumor Necrosis Factor, which is often overproduced in patients that have chronic immune diseases.

Full browser ?